New advances in neuropsychological assessment: the relationship between cognitive function and brain amyloid deposition

Yanlu Huang; Qihao Guo

doi:10.13406/j.cnki.cyxb.002921

您当前的位置：

首页 >

文章列表页 >

New advances in neuropsychological assessment: the relationship between cognitive function and brain amyloid deposition

Psychological assessment of cognitive impairment | 更新时间：2022-06-24

- New advances in neuropsychological assessment: the relationship between cognitive function and brain amyloid deposition
- Journal of Shanxi Agricultural Sciences Vol. 46, Issue 11, Pages: 1287-1290(2021)
- 作者机构：
  
  上海交通大学附属第六人民医院老年病科，上海　200233
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.002921
  CLC： R74
- Published：28 November 2021，
  
  Received：27 July 2021，
扫描看全文
Yanlu Huang, Qihao Guo. New advances in neuropsychological assessment: the relationship between cognitive function and brain amyloid deposition. [J]. Journal of Shanxi Agricultural Sciences 46(11):1287-1290(2021)
DOI：

Yanlu Huang, Qihao Guo. New advances in neuropsychological assessment: the relationship between cognitive function and brain amyloid deposition. [J]. Journal of Shanxi Agricultural Sciences 46(11):1287-1290(2021) DOI： 10.13406/j.cnki.cyxb.002921.

摘要

阿尔茨海默病（Alzheimer's disease，AD）是一种退行性疾病。在早期阶段，AD的特征是大脑中β淀粉样蛋白（β amyloid，Aβ）和tau蛋白的聚集和记忆力减退。本文总结了脑内Aβ与认知功能的关系，对当前Aβ如何影响认知功能（记忆、执行、语言）的研究进行了综述，同时对今后研究趋势进行展望，为Aβ沉积的识别提供新思路。

Abstract

Alzheimer's disease (AD) is a kind of degenerative disease. In the early stage

AD is characterized by the aggregation of β amyloid (Aβ) and tau proteins in the brain and memory loss. This paper summarizes the relationship between Aβ and cognitive function of the brain

reviews current research on how Aβ affects cognitive function (memory

execution and language)

and also provides an outlook on future research trends to provide new ideas for the identification of Aβ deposition.

关键词

阿尔茨海默病β淀粉样蛋白认知功能

Keywords

Alzheimer's diseaseβ amyloidcognitive function

references

Liu YH, Wang J, Li QX, et al. Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's disease[J]. Sci Adv, 2021, 7(1):eabb0457.

Aizenstein HJ, Nebes RD, Saxton JA, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly[J]. Arch Neurol, 2008, 65(11):1509-1517.

Rentz DM, Amariglio RE, Becker JA, et al. Face-name associative memory performance is related to amyloid burden in normal elderly[J]. Neuropsychologia, 2011, 49(9):2776-2783.

Doré V, Villemagne VL, Bourgeat P, et al. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease[J]. JAMA Neurol, 2013, 70(7):903-911.

Chételat G, Villemagne VL, Pike KE, et al. Independent contribution of temporal beta-amyloid deposition to memory decline in the predementia phase of Alzheimer's disease[J]. Brain, 2011, 134(Pt 3):798-807.

Amariglio RE, Becker JA, Carmasin J, et al. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals[J]. Neuropsychologia, 2012, 50(12):2880-2886.

Hedden T, Oh H, Younger AP, et al. Meta-analysis of amyloidcognition relations in cognitively normal older adults[J]. Neurology, 2013, 80(14):1341-1348.

Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study[J]. Lancet Neurol, 2013, 12(4):357-367.

Baker JE, Lim YY, Pietrzak RH, et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: a Metaanalysis[J]. Alzheimers Dement(Amst), 2016, 6:108-121.

Vogel JW, Varga Doležalová M, La Joie R, et al. Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly[J]. Neurology, 2017, 89(19):2002-2009.

Tomadesso C, de La Sayette V, de Flores R, et al. Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloidnegative amnestic mild cognitive impairment patients[J]. Alzheimers Dement(Amst), 2018, 10:269-277.

Matias-Guiu JA, Cabrera-Martín MN, Curiel RE, et al. Comparison between FCSRT and LASSI-L to detect early stage Alzheimer's disease[J]. J Alzheimers Dis, 2018, 61(1):103-111.

Sanabria A, Alegret M, Rodriguez-Gomez O, et al. The Spanish version of face-name associative memory exam(S-FNAME)performance is related to amyloid burden in subjective cognitive decline[J]. Sci Rep, 2018, 8(1):3828.

Shokouhi S, Conley AC, Baker SL, et al. The relationship between domain-specific subjective cognitive decline and Alzheimer's pathology in normal elderly adults[J]. Neurobiol Aging, 2019, 81:22-29.

Chapman S, Sunderaraman P, Joyce JL, et al. Optimizing subjective cognitive decline to detect early cognitive dysfunction[J]. J Alzheimers Dis, 2021, 80(3):1185-1196.

Perrotin A, Mormino EC, Madison CM, et al. Subjective cognition and amyloid deposition imaging: a Pittsburgh compound B positron emission tomography study in normal elderly individuals[J]. Arch Neurol, 2012, 69(2):223-229.

Tsoy E, Strom A, Iaccarino L, et al. Detecting Alzheimer's disease biomarkers with a brief tablet-based cognitive battery: sensitivity to Aβ and tau PET[J]. Alzheimers Res Ther, 2021, 13(1):36.

Sánchez-Benavides G, Salvadó G, Arenaza-Urquijo EM, et al. Quantitative informant-and self-reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOEε4[J]. Alzheimers Dement(Amst), 2020, 12(1):e12127.

Pérez-Cordón A, Monté-Rubio G, Sanabria A, et al. Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort[J]. Sci Rep, 2020, 10(1):17721.

Yoon HJ, Kim SG, Kim SH, et al. Distinct neural correlates of executive function by amyloid positivity and associations with clinical progression in mild cognitive impairment[J]. Yonsei Med J, 2019, 60(10):935-943.

Landau SM, Horng A, Jagust WJ, et al. Memory decline accompanies subthreshold amyloid accumulation[J]. Neurology, 2018, 90(17):e1452-e1460.

Aschenbrenner AJ, Balota DA, Tse CS, et al. Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults[J]. Neuropsychology, 2015, 29(3):368-381.

Jung Y, Whitwell JL, Duffy JR, et al. Amyloid burden correlates with cognitive decline in Alzheimer's disease presenting with aphasia[J]. Eur J Neurol, 2014, 21(7):1040-1043.

Eyigoz E, Mathur S, Santamaria M, et al. Linguistic markers predict onset of Alzheimer's disease[J]. EClinicalMedicine, 2020, 28:100583.

Whitwell JL, Weigand SD, Duffy JR, et al. Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech[J]. Neuroimage Clin, 2016, 11:90-98.

Adamczuk K, De Weer AS, Nelissen N, et al. Functional changes in the language network in response to increased amyloid β deposition in cognitively intact older adults[J]. Cereb Cortex, 2017, 27(7):3879.

Park SS, Park HS, Kim CJ, et al. Physical exercise during exposure to 40-Hz light flicker improves cognitive functions in the 3xTg mouse model of Alzheimer's disease[J]. Alzheimers Res Ther, 2020, 12(1):62.

Hou K, Zhao J, Wang H, et al. Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer's disease[J]. Nat Commun, 2020, 11(1):4790.

Zhang S, Zhao JH, Zhang YH, et al. Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer's disease[J]. Alzheimers Res Ther, 2019, 11(1):54.

Jagust W. Is amyloid-β harmful to the brain?Insights from human imaging studies[J]. Brain, 2016, 139(Pt 1):23-30.

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Advances in the study of hippocampal subregion in Alzheimer's disease

Research advances of ferroptosis in Alzheimer's disease

Interaction between education and apolipoprotein E genotype on regulating cognitive function and brain network activity in patients with mild cognitive impairment

Diagnosis of Alzheimer's disease based on whole-brain radiomics

Research progress of the characteristics of abnormal visual pathway and its clinical application in patients with Alzheimer's disease

Related Author

Shuyue Lü

Wenyue Sun

Fan Wu

Qing Zhao

Xu Pengjuan

Gao Jing

Qiao Xinrui

Zhao Jingwen

Related Institution

Department of Neurology, South Lake, China-Japan Union Hospital of Jilin University, Jilin Provincial Engineering Laboratory of Memory and Cognitive Impairment Disease

School of Integrative Medicine,Tianjin University of Traditional Chinese Medicine

Office of Academic Research,Tianjin Sino-German University of Applied Sciences

Department of Geriatrics，Nanjing Drum Tower Hospital，The Affiliated Hospital of Nanjing University Medical School, Nanjing Drum Tower Hospital，The Affiliated Hospital of Nanjing University Medical School

Department of Neurology, Nanjing Drum Tower Hospital，The Affiliated Hospital of Nanjing University Medical School

⁰